Localization of the voltage-dependent anion channel-1 Ca2+-binding sites

Photoreactive azido ruthenium (AzRu) has been recently shown to specifically interact with Ca(2+)-binding proteins and to strongly inhibit their Ca(2+)-dependent activities. Upon UV irradiation, AzRu can bind covalently to such proteins. In this study, AzRu was used to localize and characterize Ca(2+)-binding sites in the voltage-dependent anion channel (VDAC). AzRu decreased the conductance of VDAC reconstituted into a bilayer while Ca(2+), in the presence of 1M NaCl, but not Mg(2+), prevented this effect. AzRu had no effect on mutated E72Q- or E202Q-VDAC1 conductance, and [(103)Ru]AzRu labeled native but not E72Q-VDAC1, suggesting that these residues are required for AzRu interaction with the VDAC Ca(2+)-binding site(s). AzRu protected against apoptosis induced by over-expression of native but not E72Q- or E202Q- murine VDAC1 in T-REx-293 cells depleted of endogenous hVDAC1. Chymotrypsin and trypsin digestion of AzRu-labeled VDAC followed by MALDI-TOF analysis revealed two AzRu-bound peptides corresponding to E72- and E202-containing sequences. These results suggest that the VDAC Ca(2+)-binding site includes E72 and E202, located, according to a proposed VDAC1 topology model, on two distinct cytosolic loops. Furthermore, AzRu protection against apoptosis involves interaction with these residues. Photoreactive AzRu represents an important tool for identifying novel Ca(2+)-binding proteins and localizing their Ca(2+)-binding sites.     

Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells

1. Download high-res image (151KB)
2. Download full-size image

     

Interaction of a monoclonal antibody with the urease of Ureaplasma urealyticum

The monoclonal antibody (mAb) U.u. 5B2 against the urease of U. urealyticum (U.u) serotype 8, was affinity purified and was found to be an IgG 1 type, with an apparent dissociation constant of 2.9 × 10⁻¹⁰ M. Immunoblot analysis of the cytoplasmic proteins of U.u electrophoresed under non-denaturing conditions showed a reaction with a major and a minor band corresponding to the urease activity. The mAb, U.u.5B2 inhibited the urease activity up to 93% and precipitated a protein from the cytoplasm with a molecular weight of 75 kDa, corresponding to the purified urease subunit. This mAb also reacted with six other U.u serotypes but not with Jack bean urease, other urease containing bacteria or genital mycoplasma.     

Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c,AIF and Smac/Diablo

Mitochondria, central to basic life functions due to their generation of cellular energy, also serve as the venue for cellular decisions leading to apoptosis. A key protein in mitochondria-mediated apoptosis is the voltage-dependent anion channel (VDAC), which also mediates the exchange of metabolites and energy between the cytosol and the mitochondria. In this study, the functions played by the N-terminal region of VDAC1 and by VDAC1 oligomerization in the release of cytochrome c, Smac/Diablo and apoptosis-inducing factor (AIF) and subsequent apoptosis were addressed. We demonstrate that cells undergoing apoptosis induced by STS or cisplatin and expressing N-terminally truncated VDAC1 do not release cytochrome c, Smac/Diablo or AIF. Ruthenium red (RuR), AzRu, DIDS and hexokinase-I (HK-I), all known to interact with VDAC, inhibited the release of cytochrome c, Smac/Diablo and AIF, while RuR-mediated inhibition was not observed in cells expressing RuR-insensitive E72Q-VDAC1. These findings suggest that VDAC1 is involved in the release of not only cytochrome c but also of Smac/Diablo and AIF. We also demonstrate that apoptosis induction is associated with VDAC oligomerization, as revealed by chemical cross-linking and monitoring in living cells using Bioluminescence Resonance Energy Transfer. Apoptosis induction by STS, H₂O₂ or selenite augmented the formation of VDAC oligomers several fold. The results show VDAC1 to be a component of the apoptosis machinery and offer new insight into the functions of VDAC1 oligomerization in apoptosis and of the VDAC1 N-terminal domain in the release of apoptogenic proteins as well as into regulation of VDAC by anti-apoptotic proteins, such as HK and Bcl2.     

Complete Genome Sequence of Anaplasma marginale subsp. centrale

Anaplasma marginale subsp. centrale is a naturally attenuated subtype that has been used as a vaccine for a century. We sequenced the genome of this organism and compared it to those of virulent senso stricto A. marginale strains. The comparison markedly narrows the number of outer membrane protein candidates for development of a safer inactivated vaccine and provides insight into the diversity among strains of senso lato A. marginale.Sir Arnold Theiler described Anaplasma marginale as the “cause of a specific tick-borne disease of cattle” in 1908 (14), providing the first identification of a rickettsial pathogen. Two years later, Theiler isolated a less virulent organism, which he designated A. marginale subtype centrale (15). This naturally attenuated strain has been used as a live vaccine to prevent severe disease due to A. marginale senso stricto strains for 100 years. Understanding the genetic similarities and differences between the vaccine strain and wild-type A. marginale strains will provide clues as to how the vaccine provides protection. To that end, we have sequenced the A. marginale subsp. centrale vaccine strain using a whole-genome shotgun sequencing strategy.Genomic DNA, obtained from Kimron Veterinary institute, was fragmented by hydroshearing and ligated into pSmartLCKan (Lucigen). A total of 10,752 paired-end sequence reads (∼6.5× coverage) were generated. Assembly with Phrap (www.phrap.org) resulted in 148 contigs. Closure was achieved by applying the genome walking method across gap-spanning subclones and genomic DNA amplicons. For polymorphic loci, the most frequently observed subclone sequence was selected.Coding sequences (CDSs) in the single, circular, 1,206,806-bp chromosome were predicted using Glimmer2 and Glimmer3 (4, 5, 12). Annotation was as described previously for A. marginale senso stricto genomes (2, 3). There are 925 predicted CDSs, 19 pseudogenes, 37 tRNA genes, and a single set of rRNA genes in the genome. A. marginale subsp. centrale contains 10 putative genes not found in the closed-core genomes of senso stricto strains (3). Similarly, 18 genes found in senso stricto strains are absent from A. marginale subsp. centrale. This divergence is consistent with the subspecies nomenclature (15), but the findings do not resolve whether these genetic differences warrant classification of the vaccine strain as a distinct species within the genus Anaplasma (6).The ability of live A. marginale subsp. centrale to protect against a diversity of A. marginale strains indicates that epitopes critical for protective immunity are broadly conserved (11). As immunity against A. marginale can be induced by immunization with purified outer membrane protein (OMP) complexes (8-10, 13), identification of OMPs conserved between A. marginale subsp. centrale and senso stricto A. marginale may narrow the vaccine candidate list. A. marginale OMPs cluster predominately into two protein superfamilies, major surface protein 1 (Msp1) and Pfam01617/Msp2 (2). Members of the Msp1 superfamily from senso stricto strains (1, 2) are not well conserved (e.g., Msp1a, Msp1b-1, Msp1b-2, and Mlp2 to Mlp4; 13 to 48% amino acid identity) or are nonexistent (e.g., the products of Msp1b partial genes 1 to 3) in A. marginale subsp. centrale, suggesting that immunity induced by the live vaccine strain is unlikely to be associated with the Msp1 superfamily.Comparative analysis of the Pfam01617/Msp2 superfamily (2, 8) reveals both conservation and diversity. OpAG1 to OpAG3 and Msp4 are generally well conserved, while the family comprising Omp1 to Omp15 found in senso stricto strains (2, 3, 8) is reduced in A. marginale subsp. centrale: genes for the closely related proteins Omp7 to Omp9 are collapsed into a single CDS, and genes for homologs of Omp2, Omp3, Omp6, and Omp15 are missing. The OMP complex capable of inducing protective immunity contains 11 proteins (7, 8). By excluding those without homologs in the vaccine strain and the highly variable Msp2 and Msp3, the number of candidates is narrowed to six: four Msp2 superfamily members (Msp4, Omp1, Omp7, and OpAG2) and two non-superfamily members (AM779/ACIS557 and AM854/ACIS486). The degree of identity among these candidates from the vaccine strain and senso stricto A. marginale strains ranges from 63% (for OpAG2 proteins) to 88% (for Msp4 homologs). While the next steps in vaccine development will require strain analysis for epitope conservation in these candidates and immunization trials to test in vivo efficacy, progress will be accelerated using the minimal candidate list defined by the comparative genomics approach.     

Characterization of DIDS-sensitive ATP accumulation in brain synaptic vesicles

ATP is an excitatory neurotransmitter in the central and peripheral nervous system. We investigated ATP accumulation in highly purified brain synaptic vesicles (SVs). Based on the amount of ATP accumulated in SVs under the conditions used, ATP is not transported against a concentration gradient but rather appears to have a Delta mu H(+)-independent mechanism. ATP transport was inhibited by DIDS and NEM, but was not affected by Mg(2+) or by pre-incubation with nucleotides. These results suggest a unique transport mechanism that does not involve exchange with other nucleotides or protons, unlike other known neurotransmitter transport systems.